Ogawa Masahiro, Moriyama Mitsuhiko, Nakamura Hitomi, Shibata Toshikatu, Kuroda Kazumichi, Sugitani Masahiko
Division of Gastroenterology and Hepatology, Department of Medicine, Nihon University School of Medicine, 30-1 Oyaguchi-Kamimachi, Itabashi-ku, Tokyo 173-8610, Japan.
Sashiogi Recuperation Hospital, 1348-1 Hourai, Nishi-ku, Saitama city, Saitama 331-0074, Japan.
J Clin Biochem Nutr. 2024 Mar;74(2):169-178. doi: 10.3164/jcbn.23-54. Epub 2023 Aug 11.
We have previously reported that () is associated with the postoperative recurrence of hepatocellular carcinoma (HCC). Based on this fact, we verified whether mRNA expression is also associated with HCC development from chronic hepatitis C (CHC) and liver cirrhosis (LC). There were 142 cases with CHC or LC who underwent liver biopsy. Detection of mRNA in liver was performed by RT-qPCR using frozen liver biopsy tissues. We examined the association between the mRNA expression and clinical conditions and long-term outcome. We then examined the association between serum cytokine/chemokine levels and mRNA expression in 58 cases. The cumulative incidence rates of HCC development in cases with mRNA in the low expression group showed significantly lower than those in the high expression group ( = 0.0391). A significant correlation was found between mRNA expression and the extent of proliferation of atypical hepatocytes in hematoxylin and eosin-stained sections (<0.0001). mRNA expression has been associated with cytokines involved in tumorigenesis in experimental and human cancers. We found that cases with high mRNA expression were at risk for developing HCC, even if they were CHC or LC.
我们之前曾报道,()与肝细胞癌(HCC)的术后复发相关。基于这一事实,我们验证了()mRNA表达是否也与慢性丙型肝炎(CHC)和肝硬化(LC)发展为HCC有关。有142例CHC或LC患者接受了肝活检。使用冷冻肝活检组织通过RT-qPCR检测肝脏中的()mRNA。我们研究了()mRNA表达与临床状况及长期预后之间的关联。然后我们研究了58例患者血清细胞因子/趋化因子水平与()mRNA表达之间的关联。低表达组中存在()mRNA的病例发生HCC的累积发生率显著低于高表达组(P = 0.0391)。在苏木精和伊红染色切片中,()mRNA表达与非典型肝细胞增殖程度之间存在显著相关性(P<0.0001)。在实验性和人类癌症中,()mRNA表达与参与肿瘤发生的细胞因子有关。我们发现,即使是CHC或LC患者,()mRNA高表达的病例发生HCC的风险也较高。